The type-2 inositol 1,4,5-trisphosphate receptor (InsP 3 R2) was previously identified as the predominant isoform in cardiac ventricular myocytes. Here we report the subcellular localization of InsP 3 R2 to the cardiomyocyte nuclear envelope (NE 
INTRODUCTION
The inositol 1,4,5-trisphosphate receptor (InsP 3 R) family of Ca-release channels occupies a central role in the initiation and propagation of intracellular Ca-release events. These release events regulate a plethora of cellular signaling processes (reviewed in Ref. 1) . The type-2 InsP 3 R (InsP 3 R2) isoform has previously been identified as the predominate isoform expressed in ventricular and atrial cardiomyocytes (2) (3) (4) . Characterization of InsP 3 R2 channels from ventricular myocytes in planar lipid bilayers revealed that the permeation properties are very similar to the type-1 receptor (InsP 3 R1) from cerebellum but, appear to be regulated differently. The InsP 3 R2 channel is more sensitive to InsP 3 compared to InsP 3 R1 and while Ca-dependent, can be fully activated by InsP 3 at al [Ca] above 100nM (5) (6) (7) (8) .
InsP 3 R2 does not play a major regulatory role in global [Ca] homeostasis in ventricular myocytes and its functional significance is unclear (9) . However, in atrial myocytes InsP 3 R2 has been reported to be localized to junctional SR and may participate in arrythmogenisis (10, 11) . For example, Ca released by atrial InsP 3 may trigger Ca-induced Ca-release via RyR, thereby accentuating Ca oscillations (11) .
A role for InsP 3 R in cardiac dysfunction has been suggested by alterations in expression levels of the failing heart in which there appears to be an up-regulation of InsP 3 R whereas RyR2 levels decrease (12) . Also, significant evidence has been presented for the involvement of InsP 3 R in pathologies leading to Ca _ overload and apoptotic cardiomyocyte death as well as implications in the pathophysiology of cardiac arrhythmia (10, 13) .
In this study, we have identified the nuclear envelope as the primary site for subcellular localization of the type-2 InsP 3 R in ventricular myocytes.
This highly localized expression may support the functional encoding of InsP 3 -mediated Ca release in Ca-dependent nuclear-specific signaling. Consistent with this view, immunoprecipitation experiments revealed that the type-2 InsP 3 R in isolated cardiac nuclei associates with Ca /calmodulin-dependent protein kinase II (CaMKII). Co-expression of CaMKIIδ B and InsP 3 R2 followed by immunoprecipitation verifies the interaction and that the InsP 3 R2 is phosphorylated by CaMKII. Additionally, CaMKII-mediated phosphorylation of InsP 3 R2 results in a dramatic decline in channel open probability suggesting a feedback mechanism.
MATERIALS AND METHODS

Whole Heart Subcellular Fractionation
The heart fractionation procedure used was a modified procedure of Kapiloff et al. (14) . The filtrate was centrifuged 20 min at 3,800 x g max and the pellet (P1) was retained for the isolation of nuclei. The supernatant was subjected to a 15 min at 6,000 x g max centrifugation followed by 30 min 257,320 x g max sedimentation. The resulting pellet (P2) was resuspended and fractionated on a 24-50% (w/v) sucrose step gradient for 90 min at 100,000 x g max . The crude SR-enriched microsomes (SR) were recovered at the 24%-40% sucrose interface and resuspended in buffer A.
P1 from above was resuspended in buffer A1 containing 2.4 mol/L sucrose without disodium pyrophosphate. Myocyte nuclei were sedimented at ~ 50,000 x g max for 90 min. The nuclei pellets were resuspended in nuclei storage (NS) buffer (50 mmol/L HEPES (pH 7.6), 320 mmol/L sucrose, 5 mmol/L Mg-Acetate, 0.1 mmol/L Na 3 EDTA, 1 mmol/L EGTA, 1 mmol/L DTT, 0.1 mmol/L PMSF, 1 µmol/L leupeptin and pepstatin), washed and stored at -80 0 C. After initial fractionation, the majority of RyR-immunoreactive SR membranes remained in the low-speed pellet (P2) and an alternative SRmicrosome isolation strategy was used. Following the separation of the nuclei the overlying gradient material was recovered and processed with 0.65 mol/L KCl and the SR-enriched microsomes were isolated via sedimentation for 20 min at 257,320 x g max . The pellet containing SR-enriched microsomes was washed 3-4X and resuspended in NS buffer. Protein concentration was determined using BCA (Pierce, Rockford, IL).
Isolation of Nuclear Envelopes
Nuclear envelopes and nucleoplasm were separated using a modification of the methods described by Kaufmann et al. (15) and Czubryt et al. (16) . Nuclei were thawed on ice, pelleted and resuspended in NS buffer. DNase I (Roche Applied Science, Indianapolis, IN) and RNase A (Sigma-Aldrich, Saint Louis, MO) were added to 250 µg/ml and mixed for 1.0 h and then pelleted. The nuclei were lysed in NS buffer containing 1.0 mol/L NaCl. Nuclear envelopes were separated from nucleoplasm by centrifugation (16,000 x g max ). The nucleoplasmic fraction was recovered and the nuclear envelopes were resuspended in NS buffer and frozen at -80 0 C.
COS-1 Cell Transfections
COS-1 cells were transiently transfected with expression plasmids for pInsP 3 -T2 (fulllength rat type-2 InsP 3 R) (8), pIP 3 R2-Stop1078 (first 1078 amino acids of rat type-2 InsP 3 R) (5), CaMKIIδ B (17) and HA-CaMKIIδ B (hemaglutinintagged kinase) (17) using a diethylaminoethyldextran method as previously described (18) .
Microsome Preparation
Microsomes from transfected COS-1 cells were prepared as previously described (8, 18) . Microsomes for use in bilayer experiments were prepared essentially as described by Kaznacheyeva et al. (19) . Briefly, COS-1 cells were harvested in homogenization buffer (50 mmol/L Tris-HCl, pH 8.3, 1 mmol/L EDTA, 5 mmol/L sodium azide, 0.25 mmol/L PMSF, 10 µmol/L leupeptin, 10 µmol/L pepstatin, 100 µg/ml Antibodies trypsin inhibitor) and lysed with a glass/Teflon Potter-Elvehjem tissue grinder. An equal volume of buffer containing 0.5 mol/L of sucrose was added and the material was re-homogenized and centrifuged for 5 min at 1,200 x g max . The supernatant containing the microsomes was recovered and KCl and disodium pyrophosphate were added to a final concentration of 0.6 mol/L and 20 mmol/L, respectively. The material was homogenized and mixed for 30 min at 4 0 C. Following a final homogenization, the microsomes were centrifuged for 5 min at 200 x g max and the supernatant was recovered.
Finally, the microsomes were pelleted at 100,000 x g max for 10 min, resuspended in storage buffer containing 10 % sucrose and snap frozen in liquid nitrogen.
The InsP 3 R specific antibodies (T1C, T2NH, T2C) used in this study have been described previously (7, 8, 21) . Ryanodine receptor (RyR) was detected using MA3-925 (Affinity Bioreagents, Golden, CO) and a polyclonal antibody recognizing a RyR2 GST fusion protein (22) . Ca / calmodulin-dependent protein kinase II (CaMKII) antibodies G-1 and H-300, antihemaglutinin (HA) monoclonal antibody (F7) used for HA-tagged CaMKIIδ B and a monoclonal antilamin A/C antibody (346) were from Santa Cruz Biotechnology (Santa Cruz, CA).
SDS-Polyacrylamide Gel Electrophoresis and Immunoblotting
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting were performed as described previously (18) using 5% and 7.5% SDS-polyacrylamide gels. Visualization was accomplished using enhanced chemiluminescence (ECL) reagents (Amersham Life Sciences, Arlington Heights, IL).
Immunofluorescence
Rat ventricular cardiomyocytes were isolated as described by Bassani et al. (20) seeded onto coverslips coated with poly-D-lysine and processed for immunofluorescence as previously described (8) . Either anti-rabbit Oregon green-488 or Alexa Fluor-488 conjugated goat IgG were used (Molecular Probes, Eugene, OR). Imaging of the stained cells was accomplished using a Nikon Diaphot-300 inverted microscope equipped for epifluorescence and a Diagnostic Instruments Spot-II digital camera and software (Sterling Heights, MI).
CaMKII Phosphorylation of InsP 3 R2
Recombinant InsP 3 R2 or InsP 3 R2-Stop1078 were immunoprecipitated from transfected COS-1 microsomes using T2NH antibody and used as substrates for in vitro CaMKII phosphorylation as described for 32 Pincorparation assay reactions using a commercial kit (Upstate Biotechnology, Lake Placid, NY). Immune complexes were incubated for 45 min at 30 0 C with or without exogenous CaMKII (250 U) preactivated by autophosphorylation (New England Biolabs, Beverly, MA) either in the presence or absence of the specific CaMKIIinhibitor KN-93 (Seikagaku Corporation, Tokyo, Japan; 50 µmol/L).
Immunoprecipitation of InsP 3 R2 / CaMKII
Nuclei from rat heart, microsomes and cytosol from COS-1 cells were homogenized and solubilized in immunoprecipitation (IP) buffer (50 mmol/L HEPES; pH 7.6, 1.5% Triton X-100, 1.0% BSA, 10 mmol/L Mg-Acetate, 50 mmol/L NaCl 2 , 0.5 mmol/L CaCl 2 , 1 mmol/L dithiothreitol (DTT), 0.1 mmol/L phenylmethylsulfonylfluoride (PMSF), 100 µg/ml soybean trypsin inhibitor, 10 µmol/L leupeptin and 10 µmol/L pepstatin) followed by removal of insoluble material by centrifugation at 135,000 x g max . The supernatant was divided and primary antibodies were added and incubated overnight. Protein A-Sepharose CL-4B (Amersham Biosciences, Piscataway, NJ) was added and immune complexes were washed three times with IP buffer and in buffer without detergent and BSA. The IP-complexes were analyzed by western blotting.
Immunoprecipitated InsP 3 R2 / CaMKII complexes from isolated cardiac nuclei were used as a substrate in the in vitro phosphorylation reactions either with or without KN-93 (50 µmol/L) and no exogenously supplied CaMKII. The samples were resolved on SDS-PAGE, transferred to nitrocellulose membrane, exposed to film and then immuno-blotted with T2NH.
CaMKII treatment of InsP 3 R2 over-expressing microsomes
COS-1 cells were transfected with recombinant InsP 3 R2 and microsomes were prepared as described for planar lipid bilayers. Microsomes were incubated for 45 min at 30 0 C in the presence of preactivated CaMKII (250 U) with or without KN-93 (50 µmol/L) as well as no added kinase as a control. The specific CaMKII-inhibitor (KN-93) when used was also present during the preactivation of the kinase. Phosphorylation incubation conditions were as described for the in vitro phosphorylation of immunoprecipitated InsP 3 R2 without the inclusion of [γ-P 32 ]-ATP. Microsomes pretreated with phosphatase prior to exposure to CaMKII were incubated in CaMKII phosphorylation buffer (New England Biolabs, Beverly, MA) with calf-intestinal alkaline phosphatase (1:100 enzyme to protein) and protease inhibitors (0.1 mmol/L PMSF, 100 µg/ml soybean trypsin inhibitor, 10 µmol/L leupeptin and 10 µmol/L pepstatin) at 30 0 C for 30 min. The phosphatase pretreated microsomes were washed four times by pelleting at 100,000 x g and resuspended in the same buffer prior to incubation at 30 0 C for 45 min with either preactivated CaMKII (250 U), KN-93 (50 µmol/L) alone or no additions (control). In all reaction contexts, the microsomal protein concentration was 1.0 µg/µl in CaMKII phosphorylation reaction-buffer. Following treatment, the microsomes were washed once in both CaMKII and storage buffer. The microsomes resuspended in storage buffer, snap frozen in liquid nitrogen and stored for later incorporation into planar lipid bilayers.
Planar Lipid Bilayers
Single-channel recordings of recombinant InsP 3 R type-2 activities were performed by fusing microsomes into planar lipid bilayers. Bilayers were formed across a 150 µm diameter hole in the wall of a Delrin cup using a 7:3 lipid mixture of phosphatidylethanolamine and phosphatidylcholine (50 mg/ml decane, Avanti Polar Lipids, Alabaster, AL). The bilayer separated two pools (cis and trans). The microsomes were added to the cis-side of the bilayer. The channels were positively identified by their sensitivity to InsP 3 and heparin. Open probability was determined by using the half threshold crossing criteria from 3 min records at 0 mV. Unitary currents were recorded using a conventional patch clamp amplifier (Axopatch 200B, Axon Instruments, Union City, CA). The current signal was digitized at 10 kHz with a 32-bit AD/DA converter (Digidata 1322A, Axon Instruments) and filtered at 1 kHz with a low-pass eight pole Bessel filter. Data acquisition, unitary current measurement, statistical analysis and data processing were performed using commercially available software packages (pClamp V8.2, pClamp V9.0, Axon Instruments and Origin, Microcal).
RESULTS
Subcellular Localization of the Type-2 InsP 3 R to the Cardiomyocyte Nuclear Envelope
Our previous investigation of InsP 3 receptor (InsP 3 R) isoform expression in cardiac tissues demonstrated that the predominant isoform expressed in the ventricular cardiomyocyte is InsP 3 R2 (3, 8) . To further investigate the role of InsP 3 R2 in the cardiomyocyte we carried out a subcellular fractionation of rat heart using a modified procedure of Kapiloff et al. (14) . Heart homogenates were subjected to low-speed centrifugation to separate microsomes, including sarcoplasmic reticulum (SR), from heavier components such as myofibrils and nuclei (P1). The resulting supernatant was removed and pelleted by ultra-centrifugation (P2). The nuclei were then purified from the (P1) fraction by sedimentation. SR-enriched microsomes were isolated from the (P2) fraction by sucrose-gradient centrifugation.
These fractions (75 µg protein each) were immunoblotted with antibodies directed against amino-and carboxyl-terminal residues of both the type-1 (T1NH, T1C) and -2 InsP 3 R (T2NH, T2C). Additionally, an antibody against the nuclear envelope (NE) localized structural proteins lamin A and C was used. As shown in figure 1 , the lane containing the purified nuclei (Nuc) was the only fraction demonstrating significant immunoreactivity to the NH 2 -and C-terminal InsP 3 R2 specific antibodies (panels A (T2NH) and B (T2C); Nuc). This band co-migrated with the fulllength recombinant InsP 3 R2 in the adjacent lane containing transfected microsomal proteins (1 µg) (panels A and B; InsP 3 R2). No type-1 receptor was detected in the nuclei sample using the InsP 3 R1 antibodies (T1NH and T1C) when probing identically prepared blots (data not shown).
The isolation of nuclei was assessed by the enrichment of the nucleus-specific type-A lamins (lamin A and C). This antibody detected primarily a 74 kDa band (lamin A) in the total homogenate (TH) and (P1) fraction and to a lesser degree a 64 kDa band (lamin B) ( This fractionation scheme produced results suggesting that the primary subcellular site for InsP 3 R2 localization appears to be the nucleus with little if any distribution to other cardiomyocyte membrane compartments. As reported by Kapiloff et al. (14) , their fractionation protocol was intended to avoid significant nuclear destruction during the homogenization step and therefore, prevent the mixing of NE and SR membranes. In our hands, a minimal amount of nuclear disruption and SR contamination was suggested by the minor immunoreactive signal seen with the lamin antibody in the P2 fraction. However, western blotting using RyR-specific antibody revealed that a majority of SR membrane remained sequestered with the myofibrils in the low-speed pellet (P1). In order to efficiently recover SR, once the nuclei were isolated via sedimentation, the nuclei-depleted overlying material was recovered, treated with 0.6 mol/L KCl and the dissociated SR membranes were recovered by sedimentation. A comparison of equivalent amounts of the SR with NE (25 µg each) was made via western blotting using the InsP 3 R2 (T2NH) and RyR antibodies.
As predicted from the initial fractionation, T2NH resulted in a prominent InsP 3 R2-imunoreactive band in the NE fraction (Fig. 2, panel A) and a barely detectable signal in the SR. This faint SRsignal could be attributed to a contribution of low levels of InsP 3 R2 expressed in SR as reported by Lipp et al. (4) for atrial myocytes and contamination from disrupted nuclear envelopes as a consequence of homogenization or perhaps other cell types. The RyR antibody detected a prominent band in the SR microsomes and only a faint signal in the NE lane consistent with only minor SR contamination (Fig. 2, panel B) . Rat brain (minus cerebellum) microsomes (RB) were used as a positive control in each blot (100 µg).
Immunolocalization of the InsP 3 R2 in Ventricular Myocytes
Recent reports (23) (24) (25) (26) describe the immunohistochemical localization of InsP 3 R2 in several cell types as having a nuclear distribution that appears to be diffusely localized throughout the nucleoplasm within heterochromatin and euchromatin.
Given our biochemical results demonstrating the enrichment of InsP 3 R2 in the nuclear envelope of cardiomyocytes, we performed immunofluorescence on isolated rat ventricular myocytes.
Myocytes were permeabilized and immunostained with type-2 specific aminoterminal antibody (T2NH). As shown in figure 3 , a very faint fluorescent ring surrounding the nucleus is observed ( Fig. 3 ; panels A and A1). Although a compartmental membrane enrichment of InsP 3 R2 clearly exists in the cardiomyocyte NE as indicated by the western blotting data, the density of receptors appears to be low. Consistent with this are the results of Lipp et al. (4) , in which the type-2 receptor was detected only at low levels in the junctional SR of atrial myocytes that were also shown to express approximately six-fold more receptor than ventricular myocytes. In order to document the faint NE immunostaining, long exposure intervals were required, which resulted in the detection of autofluorescence typical of longitudinal mitochondrial arrays and non-specific secondary antibody absorption (27) .
No immunoreactive shell encompassing the myocyte nuclei was observed in control cells using secondary antibody alone ( Fig. 3 ; panel C and C1). We were not able to identify type-2 immunoreactivity in the SR of the ventricular myocytes.
Myocytes were reacted with InsP 3 R T2C antibody and these cells revealed a diffuse nucleoplasmic immunoreactivity similar to those described previously for the type-2 receptor. The T2C antibody was shown to cross-react with an unidentified nucleoplasmic protein (M r ~105, Fig.  4B ) and was not used further for immunolocalization studies.
Immunostaining of ventricular myocytes for the ryanodine receptor resulted in robust signals from SR components and was not observed in the nuclear envelope (Fig. 3, panels B and B1 ). This localization pattern is consistent with the immunocytochemical data of Kockskämper et al. (28) where no observable signals were detected in the nuclear envelope of atrial myocytes. These results suggest that the two intracellular release channels are differentially targeted in the myocyte and raise the possibility that the InsP 3 R2 is involved in local nuclear signaling events.
Fractionation of Nuclei
To analyze the disparate immunostaining results observed in cardiac cells with the aminoterminal and carboxyl-terminal InsP 3 R2 antibodies, we fractionated isolated nuclei into nuclear envelopes (NE) and nucleoplasm (NP) and examined the fractions for InsP 3 R2 expression. Equivalent amounts (25 µg protein) of intact nuclei, NE and NP were resolved on 5% SDS-PAGE and immunoblotted with the T2C and T2NH antibodies. As illustrated in figure 4 , the results show that InsP 3 R2 is targeted to the fraction enriched in nuclear envelopes consistent with the InsP 3 R being a multipass integral membrane protein. This is demonstrated by the enrichment of the type-2 receptor in NE as compared to intact nuclei (Nuc) (Fig. 4, panel A; T2NH and T2C) and by the absence of detectable signal in NP even following extended exposure times (not shown). Figure 4B shows the crossreactive protein observed in intact nuclei and nucleoplasmic fractions using the T2C antibody. The orientation of the InsP 3 R2 in the nuclear envelope is not known and is currently under investigation.
Given the prominent NE enrichment of InsP 3 R2 observed and to a previous report of nuclear localization of RyR (14) we probed similar panels with an antibody to RyR (Fig. 4, panel A ; RyR) and no significant immunoreactivity was observed. The absence of RyR localized to the NE is consistent with our immunocytochemical data as well as the reports of others (28) (29) (30) (31) . Samples were also immunoblotted with lamin A/C antibody (Fig. 4, panel A ; Lamin-A/C) demonstrating the exclusive association of these proteins with the NE and the absence of residual nuclear membrane in the NP. These results demonstrate that InsP 3 R2 is targeted to the cardiomyocyte nuclear membrane and conversely, as expected, RyR expression is limited to the SR (Figs. 2 and 4 ) consistent with apparently non-overlapping functional roles for these two intracellular Ca-release channels in the ventricular myocyte.
Association of InsP 3 R2 with CaMKIIδ as a nuclear macromolecular complex
The localization of the type-2 InsP 3 receptor to the NE of myocytes suggests a specialized function in the modulation of local nuclear Ca-mediated signaling events in the cardiac myocyte such as transcription or the translocation of HDAC. The transduction of local Ca signals across the interior of the nucleus has been suggested for sometime (32) (33) (34) . Koninck and Schulman (35) provided insights into a possible mechanism for CaMKII as a frequency decoder of intracellular Ca transients into discrete quanta of kinase activity.
Co-immunoprecipitation experiments were performed aimed at examining whether the type-2 InsP 3 R residing on the NE might participate in local CaMKII-signaling through direct proteinprotein interaction.
Nuclei from heart were solubilized followed by immunoprecipitation with the T2NH antibody and the immunoprecipitate was western blotted with T2C as well as with a CaMKII antibody (G-1). As shown in figure 5 , the T2NH antibody immunoprecipitated type-2 InsP 3 R (left; top) and counter immuno-detection with the CaMKII antibody (G-1) revealed an immunoreactive band (Fig. 5, left; bottom) with a M r of approximately 56-58 kDa, which is consistent with that of the predominant cardiac isoform of CaMKIIδ. In a reciprocal experiment, immunoprecipitations were performed with an alternative CaMKII antibody (H-300). Western blotting the immunoprecipitates with G-1 also showed that CaMKIIδ was recovered with InsP 3 R2 (Fig. 5, right; panels) . The identity of the putative InsP 3 R2 co-immunoprecipitate was confirmed by peptide-competition using T2NH immunogenic peptide (data not shown). These results strongly suggest that InsP 3 R2 and CaMKIIδ are associated and may form the core of a macromolecular signaling complex.
Interaction of InsP 3 R2 and CaMKIIδ by Heterologous Expression
Our immunoprecipitation data from cardiac nuclei demonstrating co-recovery of CaMKIIδ with the InsP 3 R2 was confirmed using heterologous expression in COS-1 cells. Fulllength InsP 3 R2 was co-expressed with HA-tagged CaMKIIδ B (HA-CaMKIIδ B ) (17) in transient transfections. Transfected cells were harvested and separated into microsomes and cytosolic fractions. Microsomes containing the recombinant InsP 3 R2 and any associated recombinant CaMKII were immunoprecipitated with antibodies directed against the InsP 3 R2 (T2NH, T2C) and the HACaMKIIδ B using an anti-HA antibody (F7). The immunoprecipitates from each were western blotted for both the InsP 3 R2 as well as HACaMKIIδ B . As shown in figure 6A , the HA antibody resulted in the co-recovery of InsP 3 R2 (T2NH and T2C panels) in the immunoprecipitates. In a reciprocal experiment, both InsP 3 R2 antibodies co-immunoprecipitated the HA-CaMKIIδ B (HA panel).
Control immunoprecipitations of singly transfected cells with InsP 3 R2 or HA-CaMKII using HA and InsP 3 R2 antibodies respectively, were negative (data not shown).
Co-expression experiments using a carboxyl-terminal truncation of the InsP 3 R2 (pInsP 3 R2-Stop1078) together with HACaMKIIδ B were performed to determine if the amino-terminal region of the receptor interacted with HA-CaMKIIδ B . The plasmid pInsP 3 R2-Stop1078 encodes the amino-terminal 1078 residues of the receptor and contains the ligandbinding region as well as ~500 residues of the coupling/regulatory region and is a soluble, monomeric protein (5). Cytosolic protein from COS-1 cells co-expressing the two plasmids were subjected to immunoprecipitation with T2NH and HA antibodies. As shown in figure 6B , anti-HA immunoprecipitated the HA-CaMKIIδ B and InsP 3 R2-Stop1078 expression products as a complex (T2NH panel).
The reciprocal experiment using T2NH to immunoprecipitate the InsP 3 R2-Stop1078 fragment resulted in the coprecipitation of the HA-CaMKIIδ B expression product (HA panel). Additionally, a mixing experiment using cytosolic fractions from COS cells that were singly transfected with HACaMKIIδ B or pInsP 3 R2-Stop1078 was also performed. Immunoprecipitates from the mixed fractions resulted in co-precipitation of both products using either the HA or T2NH antibodies (data not shown).
These results confirm our coimmunoprecipitation data obtained from cardiac nuclei and reveal that at least one site of interaction between the two proteins is localized to the InsP 3 R2 amino-terminal 1078 residues. Though the stoichiometry of the InsP 3 R2 / CaMKII interaction with the full-length receptor is not currently known, our results using the aminoterminal 1078 residues suggest that each receptor subunit interacts with CaMKII and that quaternary structure as a consequence of receptor subunit assembly likely does not form this site for CaMKII interaction.
Phosphorylation of InsP 3 R2 by CaMKII
The hypothesis that InsP 3 -mediated Ca release is involved in the activation of CaMKIIdependent nuclear signaling and data revealing the two proteins form a macromolecular complex raises the possibility that InsP 3 R2 may be a substrate for CaMKII phosphorylation events. In experiments aimed at determining whether CaMKII phosphorylates the InsP3R2, we expressed the full-length type-2 receptor (pInsP 3 -T2) in COS-1 cells. Microsomal fractions were solubilized and the receptor was immunoprecipitated using T2NH. The immune-complex was used as substrate for in vitro kinase assays with exogenously supplied pre-activated CaMKII (250 U, New England Biolabs) ± KN-93. The immune-complex was recovered from the kinase assay and resolved on 5% SDS-PAGE, transferred to nitrocellulose membrane and autoradiographed. As shown in figure 7A , addition of CaMKII results in the phosphorylation of the recombinant InsP 3 R2 and this incorporation of 32 P can be inhibited by KN-93. When CaMKII was omitted from the reaction, we observed a faint signal suggesting that InsP 3 R2 was phosphorylated by some associated kinase. We interpret the low level of 32 P incorporation as a consequence of the expressed receptor co-immunoprecipitating with low levels of CaMKII endogenous to COS-1 cells or perhaps another associated kinase. This activity persisted with high stringency salt washes of the immune-complex. InsP 3 R2 was phosphorylated to a much higher extent in the presence of exogenously supplied CaMKII (Fig. 7A, lane 2) . This activity was inhibited by inclusion of the CaMKII inhibitor KN-93 (Fig. 7A, lane 1) Additionally, in vitro CaMKII reactions result in the phosphorylation of a immunoprecipitated amino-terminal fragment consisting of the first 1078 residues (InsP 3 R2-Stop1078) from transfected COS-1 cell cytoplasmic fractions (Fig.  7B) . The incorporation of 32 P mirrored that of the full-length type-2 receptor. Exogenous CaMKII (250 U) resulted in significant labeling of the InsP 3 R2 fragment and this could be inhibited by the addition of KN-93 (50 µmol/L) (Fig. 7B, lanes  2 and 1, respectively) . Immunoprecipitates included in the kinase reaction without exogenously supplied CaMKII ± KN-93 (lanes 4 and 5) revealed only low levels of 32 P incorporation. This data suggests that in addition to interacting with this region of the InsP 3 R2, CaMKII also phosphorylates the receptor over this region that contains four potential CaMKII consensus phosphorylation sites. This observation however does not exclude the possibility that additional CaMKII binding and phosphorylation sites are located within the additional 1623 residues C-terminal to this fragment.
The previous results were derived from over-expressed receptor and exogenously supplied CaMKII. As a demonstration that this phosphorylation event occurs in the context of the receptor / kinase complex localized in cardiac nuclei, we immunoprecipitated the InsP 3 R2 / CaMKII complex from isolated cardiac nuclei and performed in vitro kinase assays ± KN-93 (50 µmol/L). As shown in figure 7C, 
Modulation of InsP 3 R2 Channel activity by CaMKII Phosphorylation
We next examined whether the phosphorylation of InsP 3 R2 by CaMKII had an affect on channel activity. To address this we used three experimental contexts of CaMKII presentation to the InsP 3 R2. The first used microsomes from InsP 3 R2 transfected COS-1 cells that were directly incubated in the kinase reaction either in the absence (untreated control) or presence of CaMKII (250 U) as well as CaMKII in the presence of the inhibitor KN-93 (50 µmol/L). These microsomes were then incorporated into planar lipid bilayers for channel analysis. As presented in figure 8 (gray bars) , the untreated control microsomes revealed InsP 3 -sensitive channels with a mean open probability ± S.D. of 0.430 ± 0.034 (n=6). In contrast, microsomes treated with CaMKII resulted in InsP 3 -sensitive channels that exhibited a ~91% reduction in mean open probability (P o =0.038 ± 0.044, n=6). However, the microsome samples incubated with CaMKII in the presence of the inhibitor KN-93 (CaMKII + KN-93) exhibited open probabilities similar to those of the untreated control (P o =0.446 ± 0.063, n=5 and 0.430 ± 0.034, respectively) (Fig.  8) . In a second experimental context, microsomes from COS-1 cells transiently transfected with InsP 3 R2 were first pretreated with alkaline phosphatase.
These microsomes were then incubated in the in vitro kinase reaction either alone or in the presence of preactivated CaMKII (250 U) or with KN-93 (50 µmol/L). The InsP 3 -responsive channels were then characterized in planar lipid bilayers. As shown in figure 8 (white bars), the InsP 3 -sensitive channels of the phosphatase only treated microsomes had similar open probabilities (P o =0.334 ± 0.195, n=5) as the untreated control microsomes of the first context, indicating that the phosphatase treatment and incubation in the kinase reaction had little deleterious affects on the channel activity. However, the phosphatased microsomes treated with CaMKII exhibited a significant reduction (~13 X) in the mean open probability (P o =0.026 ± 0.033, n=23) compared to the phosphatase only control. The phosphatased microsomes treated with the inhibitor KN-93 resulted in InsP 3 -sensitive channels with open probabilities (P o =0.237 ± 0.142, n=5) that are similar to those of the control. Although with this phosphatase pretreatment, intra-group channel variability was relatively high, which is likely a consequence of the manipulation prior to channel analysis; the overall results obtained using the phosphatasepretreated microsomes were very similar to the untreated context (Fig. 8) .
Finally, in a third context, COS-1 cells were co-transfected with InsP 3 R2 and CaMKIIδ B . Microsomes from these and control microsomes from cells singly transfected with InsP 3 R2 were incorporated into bilayers. As shown in figure 8 (black bars), the InsP 3 -sensitive channels from microsomes of the InsP 3 R2 / CaMKIIδ B cotransfected cells exhibited a very low mean open probability (P o =0.025 ± 0.026, n=8), compared to the microsomes containing expressed InsP 3 R2 alone (P o =0.381 ± 0.045, n=6). These results are consistent with the results from the two other contexts of CaMKII presentation to the InsP 3 R2 and suggest that CaMKII-mediated phosphorylation of InsP 3 R2 results in a dramatic reduction of the intrinsic Ca-release channel open probability. The channel activity of CaMKII treated samples was characterized by low open probability, short openings and extended closing times (τ o = 2.5 ± 0.5 ms and τ c = 31.0 ± 11.6 ms) compared to control (untreated) InsP 3 R2 samples (τ o = 18.8 ± 5.5 ms and τ c =9.5 ± 4.5 ms). At the present time the mechanism responsible for these events is not clear. This process may represent a negative feedback mechanism for InsP 3 -mediated Ca release and thus, modulate down stream signaling events. The potential mechanism of this phosphorylation induced inhibition of InsP 3 R2 channel activity such as alteration of InsP 3 and Ca sensitivities is currently under investigation.
DISCUSSION
The type-2 InsP 3 R isoform has previously been identified as the predominate isoform expressed in the ventricular cardiomyocyte. The channel is functionally activated by low levels of InsP 3 and is relatively insensitive to inhibition by high [Ca] (3, 7) . In this study, we demonstrate that the nuclear envelope is the primary site of subcellular localization of the InsP 3 R2 in the adult myocyte. Additionally, we show that the receptor forms a complex with and is a substrate for CaMKII. These observations suggest that the InsP 3 R2 is involved in nuclear Ca signaling in the cardiac myocyte.
The physiological role of the InsP 3 R2 in myocytes has remained elusive. A significant role for InsP 3 -gated Ca-release from nuclear envelope stores in the transduction of local Ca signals across the interior of the nucleus has been proposed for sometime (32) (33) (34) . Some have surmised that an independent Ca-release channel regulation of nuclear Ca-stores during physiological stimulation appears unlikely (reviewed in Ref. 36) . Recently, the examination of localized Ca-release in the cell nucleus using fluorescence recovery after photobleaching (FRAP) and the photorelease of caged InsP 3 coupled with confocal line-scanning microscopy has demonstrated independently regulated nuclear Ca stores that appear to be conducted compartmentally into the nucleus via a nucleoplasmic reticulum that is continuous with the envelope (37) . The demonstration of the NE enrichment of the InsP 3 R2 places a Ca-release channel at a subcellular site that would be ideal in effecting the regulation of nuclear-specific signaling separately from cytosolic Ca transients.
In support of this, isolated nuclei used in this study loaded with Ca indicators (fluo-3, fluo-5N/AM) have been shown to release Ca in an InsP 3 -dependent, heparin-sensitive fashion. In the case of nuclei perfused with fluo-3, InsP 3 addition raises nuclear Ca content by nearly 20%. The possibility that the myocyte nuclear envelope represents a significant Ca store is demonstrated by the diminution of membrane permeant fluo-5N signal in response to InsP 3 and adenophostin (38) .
Evidence has been presented suggesting that CaMKII is capable of decoding the frequency of Ca spikes into distinct amounts of nuclear kinase activity (35) and that CaMKII is involved in mediating Ca-dependent regulation of nuclear transcription in cardiac myocyte hypertrophicsignaling (39) . The possibility that nuclear InsP 3 -mediated signaling is involved in the activation of CaMKII is consistent with a recent study by Wu et al. (40) where the stimulation of rabbit ventricular myocytes by ET-1 resulted in the nuclear export of GFP-HDAC5. This translocation was blocked by 2-APB, W-7 and the kinase inhibitor K-252a suggesting the involvement of InsP 3 Fig. 1 . Subcellular localization of InsP 3 R2 by fractionation of rat heart. Heart homogenate (TH) was fractionated into a low-speed pellet (P1) containing myofibrils and nuclei and the accompanying supernatant was pelleted by ultracentrifugation (P2). Cardiac nuclei (Nuc) and SR-enriched microsomes (SR) were obtained from each of these pelleted fractions, respectively. 75 µg of protein from each fraction was resolved by SDS-PAGE followed by immunoblotting. Panels A-C represent immunoblots resulting from three identically loaded gels probed with the InsP 3 R2 (T2NH, T2C) and lamin A/C antibodies. The arrowheads in panel C indicate the A and C lamin isoforms. Microsomes (1 µg protein) over-expressing the full-length InsP 3 R2 were loaded as a positive control. Rat heart nuclei were solubilized and subjected to immunoprecipitation using InsP 3 R2 (T2NH) or CaMKII antibodies. Recovered immunoprecipitates were resolved on SDS-PAGE for western blotting with both InsP 3 R2 (T2C) (top panels) and a CaMKII antibody (bottom panels). 
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